Mycobacteria in Pathogenesis of Sarcoidosis

To the Editor:
We read with great interest the study by Brown et al (February 2003) 1 investigating the role of bloodstream cell wall-deficient forms (CWDFs) of mycobacteria in the pathogenesis of sarcoidosis. CWDFs have been implicated in the pathogenesis of sarcoidosis for some considerable time 2 ; however, this is the first study investigating bloodstream CWDFs since the provocative study of Almenoff et al 3 in 1996, who cultured CWDFs of likely Mycobacterium tuberculosis origin from a high proportion of sarcoid patients but from none of a control group. In the present study, a much greater number of patients and control subjects were recruited, and all patients had blood cultures within 6 months of diagnosis. CWDFs were not identified more frequently in patients compared to control subjects (38% vs 41%, although in a further one fourth of cases there was observer disagreement), prompting the authors to suggest that investigating bloodstream CWDFs is unlikely to be a fruitful etiologic approach in sarcoidosis.
In contrast, we feel that this conclusion is suspect. Human leukocyte antigen association studies 4 suggest that susceptibility or resistance to the development of sarcoidosis may relate to carriage of particular class II alleles, and therefore the presence of CWDFs in an equal proportion of healthy control subjects does not necessarily exclude an etiologic role in sarcoidosis. Moreover, the timing of blood culture may have had a critical bearing on the number of positive yields. Sarcoidosis is characterized by granulomatous inflammation whose function is a presumed "walling-off" of offending antigens. It is possible, therefore, that bacteremia only occurs very early in the disease course before granulomatous structures are fully developed. Mycobacteremia may also not occur in all patients and, perhaps, is confined to only those with multisystem involvement. An important aspect of interpretation of the data from this study should therefore include a correlation of the number of positive blood culture findings with time from disease onset, not necessarily diagnosis, and the presence of extrapulmonary manifestations. If no such correlation exists, we would concur that an etiologic role for these organisms could not be supported and that tissue-based approaches are likely to the most productive way forward.
